Pharmacy Benefit Drugs (for Arizona Only)
Defines UnitedHealthcare Community Plan of Arizona reimbursement policy requiring certain high-cost injectable specialty drugs be billed and reimbursed only under the outpatient pharmacy benefit (not on medical professional or outpatient facility claims). Applies to providers and facilities serving Arizona members.
Revised list of specialty drugs that will be denied from paying on a medical professional and outpatient facility claim.
Added Alhemo (HCPCS codes C9399, J3490, and J3590) to the denied-on-medical list.
Added Epysqli (HCPCS code Q5151) to the denied-on-medical list.
Added Hemgenix (HCPCS code J1411) to the denied-on-medical list.
Added Hympavzi (HCPCS code J7172) to the denied-on-medical list.
Added Qfitlia (HCPCS codes C9399, J3490, and J3590) to the denied-on-medical list.
Applicable Codes section: Added HCPCS codes J1411, J7172, and Q5151.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.